Title: Surgical Management of Male Breast Cancer: A Tertiary Care Centre Experience
Authors: Vaibhav Vikas, Naraindas Kewlani
DOI: https://dx.doi.org/10.18535/jmscr/v5i6.62
Abstract
Male breast cancer is an extremely rare condition with an incidence of 1/100000 men. The peak incidence is around the seventh decade of life. Risk factors for male breast cancer include genetic factors and hormonal abnormalities. Majority of the cases present in advanced stage due to lack of awareness. Pathologically, most of the cases are invasive ductal carcinoma. In this article we present a review of 3 cases of male breast cancer detected over a period of 4 years at a tertiary care health centre in India.
Keywords- Male breast cancer, ductal carcinoma, lobular carcinoma, modified radical mastectomy.
References
1. 1. Fentiman IS, Fourquet A, Hortobagyi GN: Male breast cancer. Lancet 2006, 367:595-604.
2. Gennari R, Curigliano G, Jereczek-Fossa BA, Zurrida S, Renne G, Intra M, Galimberti V, Luini A, Orecchia R, Viale G, Goldhrisch A, Veronesi U: Male breast cancer: a special therapeutic problem. Anything new? (Review). Int J Oncol 2004, 24:663-670.
3. Weir HK, Thun MJ, Hankey BF, et al. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst. 2003; 95(17):1276-1299.
4. Jemal A, Siegel R, Ward E et al.: Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71-96.
5. Stalsberg H, Thomas DB, Rosenblatt KA, et al. Histologic types and hormone receptors in breast cancer in men: a population- based study in 282 United States men. Cancer Causes Control. 1993;4(2):143-151.
6. Anderson WF, Althuis MD, Brinton LA, Devesa SS: Is male breast cancer similar or different than female breast cancer? Breast Cancer Res Treat 2004, 83:77-86.
7. Agrawal, A., Ayantunde, A. A., Rampaul, R. & Robertson, J. F. Male breast cancer: a review of clinical management. Breast Cancer Res Treat, 2007;103(1), 11-21.
8. Korde LA, Zujewski JA, Kamin L et al.: Multidisciplinary meeting on Male Brest cancer: summary and research recommend-dations. J Clin Oncol 2010; 28(12): 2114-2122.
9. Brinon LA, Richesson DA, Gierach GL et al.: Prospective evaluation of risk factors for male breast cancer. J Natl Cancer Inst 2008; 100(20): 1447-1481.
10. Goodman, M. T., Tung, K. H., Wilkens, L. R. Comparative epidemiology of breast cancer among men and women in the US, 1996 to 2000. Cancer Causes Control, 2006;17(2):127-36.
11. Lanitis, S., Rice, A. J., Vaughan, A., Cathcart, P., Filippakis, G., Al Mufti, R., Hadjiminas, D. J. Diagnosis and management of male breast cancer. World J Surg, 2008;32(11):2471-6.
12. National Cancer Institute. Surveillance Epidemiology and End Results (SEER): Cancer Statistics. Bethesda (MD): National Cancer Institute 2011. http://seer.cancer.gov/statistics/
13. Gomez-Raposo C, Zambrana Tevar F, Sereno Moyano M et al.: Male breast cancer. Cancer treat rev 2010; 6(6): 451- 457.
14. De los Santos, J. F. & Buchholz, T. A. Carcinoma of the male breast. Curr Treat Options Oncol, 2000;1(3):221-7.
15. Kiluk JV, Lee MC, Park CK et al.: Male breast cancer: management and follow-up recommendations. Breast J 2011; 17(5): 503-509.
16. Cutuli B, Le-Nir CC, Serin D et al.: Male breast cancer: evolution of treatment and prognostic factors: analysis of 489 cases. Crit rev Oncol Hematol 2010; 73(3): 246-254.
17. Ribeiro G, Swindell R: Adjuvant tamoxifen for male breast cancer (MBC). Br J Cancer 1992; 65(2): 252-254.
18. Ribeiro GG, Swindell R, Harris M et al.: A review of the management of the male breast carcinoma based on an analysis of 420 treated cases. Breast 1996; 5: 141-146.